CD Biosynsis provides expert E. coli CRISPRi Gene Repression Services, offering precise, tunable, and non-permanent control over endogenous gene expression. CRISPRi (CRISPR Interference) utilizes a catalytically inactive Cas9 (dCas9) and a guide RNA (gRNA) to physically block transcription initiation or elongation, providing a powerful tool for metabolic pathway optimization, essential gene study, and high-throughput functional screening. Our service covers the entire design and validation process: from dCas9 integration and gRNA library design to tunable repression optimization and functional analysis. We specialize in designing robust, low-leaky repression systems for challenging targets and complex regulatory networks.
Get a QuoteCRISPRi provides a superior alternative to traditional gene knockdown methods (like antisense RNA) by offering unparalleled targeting specificity and flexibility. The repression level can be precisely tuned by controlling the expression of dCas9 or the gRNA (typically using an inducible promoter like the Tet or L-arabinose system). This tunability is essential for studying genes whose complete knockout would be lethal (essential genes) or for balancing flux through metabolic pathways. We leverage optimized dCas9 expression systems and highly effective gRNA designs targeting the transcription start site to achieve deep and reliable gene repression across multiple targets simultaneously.
dCas9 Vector Cloning
Cloning of the dCas9 gene into expression vectors with customizable inducible promoters (e.g., Tet-on, LacI) for tight control over the repression system.
Chromosomal dCas9 Integration
Stable genomic knock-in of the dCas9 cassette to eliminate plasmid instability issues and ensure uniform expression across cell generations.
Host Strain Preparation
Preparation and quality control of the E. coli host strain (e.g., removing native Cas systems) to maximize CRISPRi efficiency and specificity.
gRNA Library Design
Computational design of optimal gRNAs targeting the non-template strand near the Transcription Start Site (TSS) for maximum repression efficiency.
Tunable Promoter Selection
Selection and testing of promoters for gRNA or dCas9 to achieve a gradient of repression, from mild knockdown to nearly complete silencing.
Off-Target Screening
Bioinformatic and experimental validation to ensure that the chosen gRNAs only target the intended gene and minimize unwanted side effects.
Multiplexed Repression
Simultaneous repression of multiple target genes using engineered gRNA arrays for studying complex regulatory or metabolic networks.
Essential Gene Study
Precise, low-level repression protocols allowing the viability of the strain to be maintained while studying the function of essential genes.
Functional Phenotype Screening
Integration of CRISPRi with high-throughput screening platforms to link gene repression to specific phenotypes (e.g., growth rate, metabolite production).
A sequential process ensuring maximum repression efficacy and specificity.
dCas9 System Construction
gRNA Design & Cloning
Repression Optimization
Functional Validation & Delivery
Strain Preparation: Chromosomal integration or plasmid design for constitutive or inducible dCas9 expression.
QC: Verification of dCas9 expression via Western blot or colony PCR.
Target Analysis: Computational design of gRNAs and off-target prediction for the target gene(s).
Cloning: Insertion of the optimal gRNA cassette into the gRNA expression vector.
Repression Test: Initial small-scale testing of the CRISPRi system in the dCas9 host strain.
Tuning: Optimization of induction parameters (e.g., inducer concentration) to achieve the desired repression level.
Highly Tunable Repression
Ability to achieve a gradient of knockdown (50% to >99%) by adjusting inducer concentration, essential for pathway balancing.
Superior Specificity
gRNA-guided targeting ensures repression is highly specific to the desired locus with minimal off-target effects compared to shRNA.
Multiplexing Capability
Simultaneously target and repress multiple genes within a single E. coli cell to study complex gene interactions or pathways.
Reversible Control
Repression is non-permanent and can be reversed by removing the gRNA expression or dCas9 inducer, allowing time-course experiments.
"The CRISPRi system provided by CD Biosynsis was essential for our essential gene study. We were able to precisely tune the expression level without causing cell death, something we couldn't achieve with gene knockout."
Dr. Emily Roth, PI, Microbiology Research Center
"Their gRNA design optimization was flawless. We achieved over 95% repression of our target metabolic enzyme, which successfully shunted flux to our desired product, drastically increasing our yield."
Mr. Kevin Zhou, R&D Manager, Industrial Biotechnology
"We used the multiplexed repression service to screen multiple pathway interactions. This high-throughput approach saved us months of work compared to individual plasmid manipulations."
Ms. Lisa Nguyen, Research Scientist, Synthetic Biology
"The integration of the dCas9 into a stable chromosomal locus solved our issues with expression variability. The repression effect is now highly reproducible across all our fermentation runs."
Dr. Raj Patel, Principal Investigator, Department of Molecular Engineering
"The reversible nature of their CRISPRi system was pivotal for our time-course experiments. We could switch the gene expression on and off precisely, providing clean data for our kinetic models."
Dr. Clara Rodriguez, Chief Scientist
How deep can the repression level be?
Depending on the target gene and gRNA design, we can achieve repression levels ranging from 50% knockdown to over 99% (near complete silencing), which is quantified via qRT-PCR analysis of mRNA levels.
What makes CRISPRi better than traditional antisense RNA?
CRISPRi offers superior specificity, as it relies on precise sequence matching by the gRNA. It is also generally more efficient and the repression strength is highly tunable through the control of dCas9 or gRNA expression.
Can CRISPRi be used on essential genes?
Yes. The tunable nature of CRISPRi is one of its greatest advantages for essential genes. By inducing a partial knockdown, we can study gene function and the phenotypic consequences without immediately causing cell death.
What controls the tunability of the repression?
Tunability is controlled by using inducible promoters (e.g., Tet, Lac) for the expression of the dCas9 protein or the gRNA. By varying the concentration of the corresponding inducer molecule (e.g., aTc, IPTG), we can precisely control the amount of dCas9 binding and thus the repression level.
How much does Metabolic Engineering services cost?
The cost of Metabolic Engineering services depends on the project scope, complexity of the target compound, the host organism chosen, and the required yield optimization. We provide customized quotes after a detailed discussion of your specific research objectives.
Do your engineered strains meet regulatory standards?
We adhere to high quality control standards in all strain construction and optimization processes. While we do not handle final regulatory approval, our detailed documentation and compliance with best laboratory practices ensure your engineered strains are prepared for necessary regulatory filings (e.g., GRAS, FDA).
What to look for when selecting the best gene editing service?
We provide various gene editing services such as CRISPR-sgRNA library generation, stable transformation cell line generation, gene knockout cell line generation, and gene point mutation cell line generation. Users are free to select the type of service that suits their research.
Does gene editing allow customisability?
Yes, we offer very customised gene editing solutions such as AAV vector capsid directed evolution, mRNA vector gene delivery, library creation, promoter evolution and screening, etc.
What is the process for keeping data private and confidential?
We adhere to the data privacy policy completely, and all customer data and experimental data are kept confidential.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.